Montelukast salts and pharmaceutical compositions containing the same
AssigneeGenetic S.P.A.
InventorsGiuseppe Caliendo, Giuseppe Cirino, Ferdinando Fiorino, Francesco Frecentese, Marcelo Nicolas Muscara', Elisa Perissutti, Antonio Petti, Fiorentina Roviezzo, Vincenzo Santagada, Beatrice Severino
Life of this patent
Estimating the term…
Abstract
The present invention relates to salts of Montelukast with β2 adrenergic agonists, pharmaceutical compositions containing the same and the use thereof in the treatment of respiratory inflammatory pathologies, obstructive pathologies and allergen-induced airway dysfunctions. The invention further relates to the process for preparing said salts.
Claims8
A salt formed between Montelukast and a ß2 adrenergic agonist, wherein the ß2 adrenergic agonist is, selected from the group consisting of Fenoterol, Orciprenaline, Salbutamol, Terbutaline, Bambuterol, Clenbuterol, Formoterol, Salmeterol, Vilanterol, Indacaterol and Olodaterol.
Dependencies are inferred from the claim text.